Supporting evidence
Sleeve gastrectomy × HbA1c
- Authoritative support
- 3
- Available studies
- 3
- Unavailable support
- 0
Available supporting studies
Study 1 · Limited
Bariatric surgery improves glucose homeostasis in type 2 diabetes.
Rct
- Comparison
- Patients receiving medical therapy for type 2 diabetes. · Patients undergoing roux en y gastric bypass surgery. · Patients undergoing sleeve gastrectomy surgery.
- Duration / follow-up
- 3120 weeks
Relevant effects
Percent change
29.8
Percent change
30.4
Percent change
30.4
Study 2 · Included
Bariatric surgery improves insulin sensitivity in type 2 diabetes
Rct
- Comparison
- Participants undergoing roux en y gastric bypass surgery. · Participants undergoing sleeve gastrectomy surgery. · Healthy individuals without obesity and T2D serving as controls.
- Duration / follow-up
- 9 weeks
Relevant effects
Percent change
21
Percent change
26
Study 3 · Limited
Robotic surgery may improve metabolic outcomes in type 2 diabetes
- Comparison
- Aimed to enhance incretin response and reduce glucagon levels. · Targeting sympathetic overactivity and autonomic dysfunction.
- Duration / follow-up
- 52 weeks
Relevant effects
Absolute change
0.9
Absolute change
2.9